These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 218538)

  • 1. Stability and immunogenicity of empty particles of foot-and-mouth disease virus.
    Rweyemamu MM; Terry G; Pay TW
    Arch Virol; 1979; 59(1-2):69-79. PubMed ID: 218538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus.
    Rowlands DJ; Sangar DV; Brown F
    J Gen Virol; 1975 Mar; 26(3):227-38. PubMed ID: 235596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines.
    Twomey T; Newman J; Burrage T; Piatti P; Lubroth J; Brown F
    Vaccine; 1995 Nov; 13(16):1603-10. PubMed ID: 8578849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
    Stave JW; Card JL; Morgan DO
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the minor polypeptides in the foot-and-mouth disease particle.
    Sangar DV; Rowlands DJ; Cavanagh D; Brown F
    J Gen Virol; 1976 Apr; 31(1):35-46. PubMed ID: 177728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The specific detection of foot-and-mouth disease virus whole particle antigen (140S) by enzyme labelled immunosorbent assay.
    Elzein EM; Crowther JR
    J Hyg (Lond); 1979 Aug; 83(1):127-34. PubMed ID: 222837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal stability of foot-and-mouth disease virus.
    Doel TR; Baccarini PJ
    Arch Virol; 1981; 70(1):21-32. PubMed ID: 6277281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus.
    Doel TR; Chong WK
    Arch Virol; 1982; 73(2):185-91. PubMed ID: 6293410
    [No Abstract]   [Full Text] [Related]  

  • 9. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.
    Cartwright B; Chapman WG; Brown F
    J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of 140S particles in foot-and-mouth disease virus (FMDV) vaccine by using the computer analyzing system.
    Shirai J; Chatchawanchonteera A; Sinsuwongwat W; Makarasen P; Sugimura T
    Nihon Juigaku Zasshi; 1990 Jun; 52(3):621-30. PubMed ID: 2166853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of foot-and-mouth disease virus. I. Sensitization of the 140S virion by antibody also reactive with the 12S protein subunit.
    Hardy MM; Moore DM
    J Gen Virol; 1981 Aug; 55(Pt 2):415-27. PubMed ID: 6169797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface structure and RNA-protein interactions of foot-and-mouth disease virus.
    Morrell DJ; Mellor EJ; Rowlands DJ; Brown F
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1649-58. PubMed ID: 3035064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
    Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
    Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physical chemical measurement of 140S particles of the foot-and-mouth disease virus].
    Fayet MT; Fargeaud D; Louisot P; Stellmann C; Roumiantzeff M
    Ann Inst Pasteur (Paris); 1971 Jul; 121(1):107-18. PubMed ID: 4329751
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
    Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
    Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins.
    Meloen RH; Briaire J
    J Gen Virol; 1980 Nov; 51(Pt 1):107-16. PubMed ID: 6257830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
    Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
    Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the immunogenic potencies of purified inactivated foot-and-mouth disease virus particles with variable amounts of VP1 protein (author's transl)].
    Bernard S; Grosclaude J; Adamowicz P; Guerche J
    Ann Rech Vet; 1977; 8(1):79-94. PubMed ID: 195512
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
    Meloen RH; Rowlands DJ; Brown F
    J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.